AllDocs -> cancers

G:\STUDIES-2006\Cervical Cancer \Meeting 3 - Jul06\7-18-06 Meeting Agenda.doc Task Force to Study Cervical Cancer Prevention , Detection and Education July 18, 2006, 1:00pm to 4:00pm Room 214, Cross Office Building AGENDA 1:00pm Introductions 1:15pm Review and Updates Review of Initial Report Updates – Recent News, Reports and Resources 1:45pm Task Force Discussion/Work Session Remaining Duties and Schedule Developing a Statewide Cervical Cancer Prevention Plan – Next Steps 2:30pm Break 2:45pm Presentation / Maine Health Data Organization - Overview of Available Data (Al Prysunka) 3:15pm Presentation / Family Planning Association of Maine – Pap Test Data (Evelyn Kieltyka) 3:45pm Planning for Next Meeting 4:00pm Adjournment Next Meeting -- August ...

USA Office 19355 Business Center Dr. Suite # 8 Northridge, CA 91324 USA Tel (818) 709-2468 Fax (818) 709-2464 www.gm-ideas.com Norway Office Martin Linges vei 25 POB 1, N-1330 Fornebu NORWAY Phone: +47 67 82 71 71 Fax: +47 67 82 71 72 www.gm-ideas.com FOR IMMEDIATE RELEASE July 25, 2006 CONTACT: Northridge Oslo Patrick Moody Thomas Langaard Vice President, Marketing Executive Vice President and (818) 280-0420 x107 Chief Operating Officer patrick.moody@gm-ideas.com +47 6782 7167 www.gm-ideas.com thomas.langaard@gm-ideas.com www.gm-ideas.com Swiss Researchers Report on Promising New Compounds for Cancer Detection and Treatment Researchers Use Europe’s First Gamma Medica-Ideas FLEX Pre-Clinical Imaging System to Slash Development Time for ...

INFORMATION TELEVISION NETWORK ONE PARK PLACE 621 NW 53RD ST BOCA RATON, FL 33428 1-800-INFO-ITV www.itvisus.com © 2005 Information Television Network. All Rights Reserved. The TV Series www.HealthyBodyHealthyMind.com Produced By: Journal Breast Cancer : Early Detection Page 2 UNDERSTANDING BREAST CANCER Breast cancer is the most common cancer in women and women living in North America have the highest rate of breast cancer in the world. The rate has been steadily rising since 1980 and continues to rise in women aged 50 or older. And in Europe, while Western European women are diagnosed with breast can- cer more often, there is a higher rate of cancer related mortality among Eastern European women. In 2005, it is estimated that more than one million women around the ...

An Automated Computer Aided Breast Cancer Detection System Varsha H. Patil 1 , Dattatraya S. Bormane 2 and Vaishali S. Pawar 3 1 Assistant Professor, Computer Engineering Department, K. K. Wagh Institute of Engineering Education and Research, Nashik (MS) India 2 Principal, Bharti Vidyapeeth’s College of Engineering for Women, Pune (MS), India. 3 Lecturer, Computer Engg Dept., NDMVP’s College of Engineering , Nashik (MS), India. vhpatil@kkwagh.org http://www.kkwagh.org Abstract Each year, 182,000 women are diagnosed with breast cancer and 43,300 die. One woman in eight either has or will develop breast cancer in her lifetime. If detected early, the five-year survival rate exceeds 95%. Mammography can detect very early breast tumors, when they are too small to be felt. In fact, most ...

Paving the Way for Early Detection of Cancer Dan Krotz, dakrotz@lbl.gov A diagnostic test that exposes the first inkling of cancer in a cell’s nucleus could someday become a reality, thanks to a team of Berkeley Lab and Purdue University scientists who have developed a way to automatically map the three-dimensional distribution of proteins within the nuclei of human mammary cells. The technique, which couples state-of-the-art fluorescent imaging with computer-driven image analysis, could enable doctors to detect aggressive cancers in their earliest stages—giving physicians more time to fight the disease. It could also allow doctors to better characterize a patient’s cancer and match him or her with the most effective therapy. “It won’t replace today’s tests, but it will give pathologists an important additional view of tissue,” says David Knowles, a scientist in ...

Quantifying the impact of prostate volumes, numbers of biopsy cores, and 5 a -reductase inhibitor therapy on the probability of prostate cancer detection using mathematical modeling Robert Serfling, Ph.D., 1 Michael Shulman, M.D., 2 G. L. Thompson, Ph.D., 3 Zhiyao Xiao, M.S., 4 Elie Benaim, M.D., 5 Claus G. Roehrborn, M.D., 6 and Roger Rittmaster, M.D. 7 1. Department of Mathematical Sciences, University of Texas at Dallas, Richardson, Texas 75083-0688, USA. 2. Department of Urology, University of Texas Southwest Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390-9110, USA. 3. Department of Chemistry, University of Texas at Dallas, Richardson, Texas 75083-0688, USA. 4. Department of Mathematics and Statistics, University of North Carolina at Charlotte, Charlotte, ...

Modeling prostate cancer detection probability using prostate specific antigen, transition and peripheral zone volumes, and numbers of biopsy cores Runninng head: Modeling prostate cancer detection probability Key words and phrases: detection probability, prostate, cancer , volume, finasteride Robert Serfling, Ph.D. 1 , Michael Shulman, M.D. 2 , G. L. Thompson, Ph.D. 3 , Zhiyao Xiao, M.S. 4 , Elie Benaim, M.D. 5 , Claus G. Roehrborn, M.D. 6 , and Roger Rittmaster, M.D. 7 February 2006 1 Department of Mathematical Sciences, University of Texas at Dallas, Richardson, Texas 75083- 0688, USA. Email: serfling@utdallas.edu. Website: www.utdallas.edu/ ~ serfling. 2 Department of Urology, University of Texas Southwest Medical Center at Dallas, 5323 ...

United States Cancer Statistics: 2002 Incidence and Mortality Table I.2: Confirmation Rates* and Detection Rates † for Cancer Mortality ‡ by Anatomic Site and International Classification of Disease (ICD) Version— United States Confirmation Rate* (%) Detection Rate* (%) Cancer site ICD–9 ICD–8A ICD–9 ICD–8A All malignant sites 84.8 82.7 83.3 82.7 Oral cavity and pharynx NA§ NA NA NA Esophagus 77.0 86.1 93.7 93.2 Stomach 93.9 90.9 88.1 89.2 Colon and rectum 95.6 95.0 92.7 92.9 Liver and intrahepatic bile duct§ NA 76.7 NA 49.6 Liver§ 70.2 NA 78.3 NA Pancreas 90.3 89.0 91.5 90.2 Larynx 69.3 ...

cancer prevention detection Media Release August 16, 2005 NEW PARTNERSHIP OFFERS HOPE FOR BETTER OUTCOMES FOR CANCER PATIENTS Cancer patients will directly benefit from an exciting and unique new partnership to promote participation in cancer clinical trials in Western Australia. The Cancer Council Western Australia today announced funding of $600,000 for a new initiative – Cancer Council Clinical Trials WA. In partnership with the Western Australian Institute for Medical Research (WAIMR), the Cancer Council will establish a centre to encourage more participation in clinical trials and to contribute to leading edge cancer research. The Cancer Council Clinical Trials program, which includes funding of $750,000 for a chair in clinical cancer ...

The major focus of our group is the development of sensitive and specific assays for early noninvasive or minimally invasive molecular detection of cancer , and the development of cancer stem cells-targeted therapies (in collaboration with the IBC&DD). Since virtually all tumors represent highly heterogeneous populations of cells, molecular analyses of surgically obtained gross or biopsy specimens are not optimal. In contrast, the most representative cancer cells, including cancer stem cells, are more likely than their normal counterparts to exfoliate into biological fluids, so we are studying multiple molecular markers, including telomerase, metalloproteinases, adhesion molecules and others, on particular populations of exfoliated and sorted cancer cells isolated from corresponding fluids. I. Molecular Cancer Detection Projects Gastrointestinal Cancers Involved: Martin Karpeh, MD; David ...

1 Horizon NJ Health Adult Preventive Guideline, July 2006 Horizon NJ Health Adult Preventive Guidelines Horizon NJ Health supports the recommendations of the following organizations as it relates to adult preventive health guidelines: • The American Cancer Society • The Advisory Committee on Immunization Practices • U. S. Preventive Services Task Force Attached are samples of recommendations from each of these organizations. The following Web sites provide complete details, references and most recent and updated recommendations for each organization. • http://www. cancer .org/docroot/PED/content/PED_2_3X_ACS_Cancer_Detection_Guidelines_36 .asp?sitearea=PED • http://www.cdc.gov/nip/menus/vaccines.htm#Schedules • http://www.ahcpr.gov/clinic/prevenix.htm Please note guidelines are subject to change and therefore you should refer to the above web- sites for the most recent recommendations. ...

Early detection of breast cancer using mammography – a position paper of the Swiss Cancer League Marcel Zwahlen 1 , Nicole Probst 2 , Brigitte Baschung 3 , Chris de Wolf 4 , Elisabeth Marty-Tschumi 5 , Bettina Borisch 6 1 Department of Social and Preventive Medicine at the University of Berne, Berne 2 Institute of Social and Preventive Medicine at the University of Zurich, Zurich 3 Swiss Cancer League, Berne 4 FDD-D&P, Développement et perspectives auprès de la Direction générale de la santé, République et Canton de Genève, Geneva 5 Delegate for Health Promotion and Prevention , Public Health Service, Sion 6 Institute of Pathology, University of Geneva, Geneva Swiss Cancer League Effingerstrasse ...

Objectives: A. Detection of Cervical Cytologic Abnormalities * * Maryland DHMH, Center for Cancer Surveillance and Control * To inform clinicians of these guidelines Minimal Clinical Elements for Cervical Cancer Detection and Diagnosis Breast and Cervical Cancer Program--October 2004 Goal: The goal of these Minimal Clinical Elements for Cervical Cancer Detection and Diagnosis is to provide clients of the Maryland Breast and Cervical Cancer Program with optimal, up-to-date screening and management C. Management of women with Cervical Intraepithelial Neoplasia and Cancer * To assist local Breast and Cervical Cancer Programs in evaluating cervical cytology results and recommended management * To bring the Minimal Clinical Elements in line with the 2001 Bethesda System Terminology for Reporting Results of Cervical Cytology * To incorporate into the Minimal Clinical ...

Skin Cancer Prevention and Early Detection AT-A-GLANCE 1995 Courtesy of the University of Texas M.D. Anderson Cancer Center “Skin cancer now appears to be as common as all other types of cancer combined.” Dr. Martin A. Weinstock, Director, Brown University Dermatoepidemiology Unit U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Centers for Disease Control and Prevention CENTERS FOR DISEASE CONTROL AND PREVENTION DEP AR TM E N T O F H E A L T H & H U M AN SER VICES • USA Page 2 2 Skin Cancer Skin cancer is the most common and most rapidly increasing form of cancer in the United States. One in six Americans will develop ...

FACT SHEET 2004 / 2005 FROM THE DIVISION OF CANCER PREVENTION AND CONTROL The National Breast and Cervical Cancer Early Detection Program, administered by the Centers for Disease Control and Prevention (CDC), helps low- income, uninsured, and under- served women gain access to life- saving screening programs for early detection of breast and cervical cancers. Many deaths from breast and cervi- cal cancers could be avoided by increasing cancer screening rates among women at risk. Deaths from these diseases occur disproportion- ately among women who are unin- sured or underinsured. Mammogra- phy and Papanicolaou (Pap) tests are underused by women who have no source, or no regular source of healthcare; women with- out health insurance; and women who immigrated to the United States within the last 10 years. ...

N AT I O N A L B R E A S T A N D C E RV I C A L C A N C E R E A R LY D E T E C T I O N P R O G R A M detection early Summarizing the First 12 Years of Partnerships and Progress Against Breast and Cervical Cancer 1991–2002 NATIONAL REPORT U.S. Department of Health and Human Services Page 2 Page 3 National Breast and Cervical Cancer Early Detection Program 1991–2002 National Report A. Blythe Ryerson, MPH Vicki B. Benard, PhD Epidemiology and Applied Research Branch Anne C. Major Program Services Branch For additional copies of this report, please contact the Centers for Disease Control and Prevention , National Center for Chronic Disease Prevention and Health Promotion Division of Cancer Prevention and Control Attn: Publications, ...

FACT SHEET 2003 FROM THE DIVISION OF CANCER PREVENTION AND CONTROL The National Breast and Cervical Cancer Early Detection Program, administered by the Centers for Disease Control and Prevention (CDC), helps low-income, uninsured, and under- served women gain access to lifesaving screening programs for early detection of breast and cervical cancers. Many deaths from breast and cervical cancers could be avoided by increasing cancer screening rates among women at risk. Deaths from these diseases occur dispro- portionately among women who are uninsured or underinsured. Mammography and Papanicolaou (Pap) tests are underused by women who have less than a high school education, are older, live below the poverty level, or are members of certain racial and ethnic minority groups. Studies show that early ...

The National Breast and Cervical Cancer Early Detection Program AT-A-GLANCE 1998 “As we move into the 21st century, public health organizations, private agencies, and professional and voluntary organizations must form partnerships to support and enrich services to the public.” David Satcher, MD, PhD Director, Centers for Disease Control and Prevention Public Education & Outreach Quality Assurance Screening & Follow-up Services Professional Education Partnerships & Coalition Development Surveillance U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Page 2 2 An estimated 2 million American women will be diagnosed with breast or cervical cancer in the 1990s, and half ...

For more information on free or low-cost mammograms and Pap tests, call us toll free at 1-888-842-6355 (select option 7) R ecognizing the value of screening and early detection , Congress passed the Breast and Cervical Cancer Mortality Prevention Act of 1990. This Act authorized critical breast and cervical cancer screening services for underserved women, including older women, women with low incomes, and women of racial and ethnic minority groups. The Act established the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) administered by the Centers for Disease Control and Prevention . Visit our Web site at: www.cdc.gov/ cancer • Since the Program’s inception, over 2 million screening tests have been provided to underserved women. • This Program provides free and low cost mammograms and Pap smear tests to ...

The National Breast and Cervical Cancer Early Detection Program 2001 “Over 1.5 million women have taken advantage of services provided through CDC’s National Breast and Cervical Cancer Early Detection Program. Now more than a decade old, this program provides recommended screening to low-income women in every state in the country. However, more women are in need of these critical services than the program can support. As a nation, we must step up our commitment to reaching all women.” Screening,Tracking, Follow-Up, and Case Management Public Education and Outreach Quality Assurance and Improvement Coalitions and Partnerships Professional Education Jeffrey P. Koplan, MD, MPH Director, Centers for Disease Control and Prevention A T A G LANCE 2001 ...

The National Breast and Cervical Cancer Early Detection Program AT-A-GLANCE 1997 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES “As we move into the 21st century, public health organizations, private agencies, and professional and voluntary organizations must form partnerships to support and enrich services to the public.” David Satcher, MD, PhD, Director Centers for Disease Control and Prevention Public Education & Outreach Quality Assurance Screening & Follow-up Services Professional Education Partnerships & Coalition Development Surveillance Page 2 2 An estimated 2 million American women will be diagnosed with breast or cervical cancer in the 1990s, and half a million will lose their lives. A dispropor- ...

Program Guidelines for Breast and Cervical Cancer Early Detection 1997 Page 2 Acknowledgments i Acknowledgments any individuals worked together to prepare this document entitled Program M Guidelines for Breast and Cervical Cancer Early Detection . These participants are gratefully acknowledged for their dedication to reducing avoidable mortality from breast and cervical cancer and for their commitment and persistence in developing the guidelines. Barbara Berner Alaska Department of Health and Social Services Lori Borelli Centers for Disease Control and Prevention Kevin Brady Centers for Disease Control and Prevention Carole Chrvala Colorado Department of Health Diane Dunet Centers for Disease Control and Prevention Julia Francisco Kansas Department of Health and Environment ...

1 Building a National Infrastructure The National Breast and Cervical Cancer Early Detection Program AT-A-GLANCE 1995 “How tragic it would be if just one woman avoided what might be a life-saving screening program because she questioned its value or simply didn’t know where to go or who to turn to.” David Satcher, M.D., Ph.D., Director, Centers for Disease Control and Prevention U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Centers for Disease Control and Prevention CENTERS FOR DISEASE CONTROL AND PREVENTION DEP AR TM E N T O F H E A L T H & H U M AN SER VICES • USA Mammograms and Pap Tests Public Education Surveillance Health Provider ...

cancer detection 6th AUSTRALASIAN MUTATION DETECTION WORKSHOP couran cove, queensland 2 nd to the 5 th August, 2006 PROGRAMME All Talks will be held in the Olympic Room Posters and Trade Displays will be located in the Landy & Jackson Rooms All refreshments will be served in the Landy & Jackson Rooms All Lunches will be served in the Restaurant Tue 1 st August, 2006 5.00pm to 6.00pm Early Registrations Wed 2 nd August, 2006 1.00pm to 3.00pm Registration, Posters and Trade Set-Up with coffee 3.00pm to 3.05pm Welcome R. Cotton and A. Fellowes 3.05pm to 3.35pm A High-throughput ...

Title of the project: Electromagnetic detection and ablation of female breast cancer Supervisor: Dr.Ir. Bert Jan Kooij Technical advisor: Dr.ing. Ioan E. Lager Description of the project: Cancer of the breast is the most common type of cancer affecting women in the Western world. Early detection of small malignant tumours increases life expectancy significantly. In close collaboration with the University Medical Center (UMC) in Utrecht we are investigating the detection and ablation of female breast tumours by means of electromagnetic radiation. By using electromagnetic radiation in the range of 1 to 10 GHz. we hope to detect tumours with a diameter as small as 1 to 3 mm. Subsequently, we aim at ablation of the detected tumour by applying high-power electromagnetic radiation focussed on the location of the detected tumour. As a first step in this research project we want to compute the electromagnetic ...

Detection of Methylated DNA in Plasma from Colorectal Cancer Patients and Controls by Real-Time PCR Analysis of Septin 9 Abstract Background – Colorectal cancer is one of the most common cancers world-wide and patients have been shown to benefit from early detection of the disease through regular screening. New population-based screening tests should attain both high sensitivity and high specificity to be effective. Tests should also be easily available and acceptable to the patient. Our approach is to provide an easily administered, blood-based test for detection of colorectal cancer . Methods – Plasma samples were collected from patients with colorectal cancer and polyps to test sensitivity of the methylation-based marker assay and from colonoscopy- verified healthy individuals to test specificity. In addition, to identify clinical conditions that could result ...

Portable near-infrared diffusive light imager for breast cancer detection Nan Guang Chen Minming Huang Hongjun Xia Daqing Piao University of Connecticut Department of Electrical & Computer Engineering Storrs, Connecticut 06269 Edward Cronin Hartford Hospital Radiology Department Hartford, Connecticut 06102 Quing Zhu University of Connecticut Department of Electrical & Computer Engineering Storrs, Connecticut 06269 Abstract. We present a frequency-domain near-infrared optical to- mography system designed for breast cancer detection , in conjunction with conventional ultrasound. It features fast optical switching, three- wavelength excitations, and avalanche photodiode as detectors. Laser diodes at 660, 780, and 830 nm are used as light sources and their outputs are distributed sequentially to one of nine source ...

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health • National Cancer Institute NIH Publication No. XX-XXXX Month 2003 Ovarian Cancer Prevention and Early Detection Study Clinical Genetics Branch Division of Cancer Epidemiology and Genetics By how much can surgery or screening reduce your risk? In cooperation with the Gynecologic Oncology Group Cancer Genetics Network W ILL M Y P RIVACY B E P ROTECTED ? Yes. All personal information obtained for the study will be kept private, and every effort will be made to protect your confidentiality. NCI is required by Federal law not to reveal any information that is collected from study participants to anyone other than persons ...

Drug tested for oral cancer detection Zila shares could double if OraTest is approved, analysts say. December 21, 2005: 3:27 PM EST By Aaron Smith, CNNMoney.com staff writer NEW YORK (CNNMoney.com) - Oral cancer is a disfiguring affliction that is difficult to detect in its early stages, which is how it manages to kill half the people it infects. "We are subduing the dangers of breast and cervical cancers in women, but we are doing nothing for one of the most insidious and heart-rending types of cancers, and that's oral cancer ," said Marc Robins, founder of The Robins Group, an institutional brokerage firm. Zila, Inc., an Arizona biotech, began late-stage testing on OraTest, its detection drug for oral cancer , earlier this month. If clinical trials for the drug are successful and if it's approved by the Food and Drug Administration, the company's stock could jump dramatically, ...

http://today.reuters.com/misc/PrinterFriendlyPopup.aspx?type=busin 1 of 2 6/28/06 9:02 AM Print this article Close This Window Zila eyes oral cancer detection market Tue Jun 20, 2006 10:31 AM ET By Nupur Sen BANGALORE (Reuters) - Zila Inc. <ZILA.O>, which earlier this month said it was in talks to divest its nutraceutical unit, is betting on what it sees as a potential $1.5 billion market for its oral cancer detection business. Zila, which had net revenue of about $6.8 million in the quarter ended April 30, sees no competition to its products -- ViziLite Plus and OraTest -- from technologies like the brush biopsy technique, where a brush is used to scrape off abnormal cells that can then be sent for a biopsy. ViziLite Plus, a chemiluminescent device that makes it easier to see abnormal tissue, is already in the U.S. market, while OraTest, a rinse that stains abnormal cells, ...